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THE DETERMINATION OF LUNG FUNCTION USING
IMPULSE OSCILLOMETRY AND SPIROMETY
by
MÉCOLE V. INGRAM
(Under the Direction of James McMillan)
ABSTRACT

This study was designed to establish normative data for individuals 18-22 years
old using oscillometry by comparing the values to spirometry. Oscillometry is a less
invasive procedure for respiratory testing than spirometry testing. One hundred and
forty-two participants completed self-assessment questionnaires, along with body
composition measurements and at least three trials each of oscillometry and spirometry
testing. The results of the study conclude that no normative data could be established in
this study over all resistance (R) and reactance (X) frequencies for males and females.
The secondary goal of this study was to examine the effects of smoking, physical activity,
and weight on forced expiratory volume (FEV1). Smoking and weight had a significant
effect on FEV1 while there was no significance to physical activity and FEV1 but a trend
was found. In conclusion, more testing needs to be conducted to create normative data for
18-22 year olds. This will assist professionals in diagnosing respiratory disorders in this
age bracket.
INDEX TERMS: Oscillometry, Spirometry, Lung function, Resistance, Reactance
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DEDICATION
This paper is dedicated to those who have changed careers multiple times and are
still trying to find themselves. It is possible to find your way. Keep searching, but have
fun while doing so, and never forget the lessons learned and people that cross your path
on your journey. To all of the constant procrastinators, one day we will learn to do things
early or on time, and when we do, we will have a masterpiece.
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Introduction
Healthy lung function is essential to having a productive and healthy life. Complications
or distress within lung structures may cause illnesses and diseases in individuals. In
addition to diseases and illnesses, respiratory performance can be attributed to age-related
system changes. As people age, there is a decrease in respiratory function (Amara,
Koval, Paterson and Cunningham, 2001). With increasing age comes airway closure at
higher lung volumes causing expiratory flow limitations and weaker respiratory muscles.
Smoking, lack of physical activity, obesity, and chest wall adiposity also affect
respiratory function (Amara et al, 2001). Accurate assessment of pulmonary function is
essential to evaluate the effect of these factors and natural life occurrences, on lung
function.
Assessing pulmonary function has gained greater attention and has been utilized
more over the past 15 years in diagnosing individuals with respiratory illness and disease.
Over the years, research has lead to improvements in the methods, technology, and
knowledge in the assessments of pulmonary function. The different methods for testing
pulmonary function include body plethysmography, spirometric testing, forced
oscillometry (FO) and impulse oscillometry (IOS). Each method has its own advantages
and disadvantages. The “gold standard” for pulmonary testing is spirometry (Kim, Kim,
Park and Hong, 2001). Spirometric testing has been shown to be valid, reliable, and
reproducible (Kim et al, 2001). Spirometric testing requires total cooperation and forced
maximal efforts, which are needed for an accurate test result, and this may be difficult to
obtain in all populations (effort dependent) causing an extreme disadvantage to
spirometric testing (Kim et al, 2001).
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Another method, which is becoming more commonly used and accepted in the
medical and clinical community, is oscillometry. DuBois first derived this new method
in 1956 (Rozen, Bracamonte and Sergysels, 1983; Neild, Twort, Chinn, McCormack,
Jones, Burney, and Cameron, 1989). Advantages to using oscillometry include its noninvasive nature passive cooperation from patients (effort independent) (Kim et al, 2001).
IOS/FO has been shown to be easy to use in all populations especially with children, the
elderly, and the disabled (Marotta, Klinnert, Price Larsen and Liu, 2003). Oscillometry
has steadily become more utilized and accepted in clinical settings and medicine. While
there appear to be many advantages to oscillometry, no normal reference standards have
been established for all ages.
Reference values for the pulmonary function test (PFT) including spirometry and
oscillometry, are used for screening patients for pulmonary diseases and to follow up on
their continued progress or regression (Nysom, Ulrik, Hesse and Dirken, 1997).
Spirometric testing assess pulmonary function airway obstruction by measuring the
forced expiratory volume at one second (FEV1). This is the amount of air that can be
forcibly expelled from the lungs in one second after maximal inspiration. If an
individual’s FEV1 is less than 80% this may indicate risk factors for cardiopulmonary
disease (CPD), stroke, or lung cancer and may also be an indicator for other risks, such
as, obesity and physical inactivity (Jakes, Day, Patel, Khaw, Oakes, and Luben, 2002).
Different reference values are used for pediatric ages (persons 18 years and younger) than
for adults (persons over 18 years old). There has been no baseline PFT data collected for
cohorts between the ages of 18-22 years old and therefore no normative values for these
age ranges have not been established. The importance of having normative data is to be
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able to identify subtle changes in respiratory function at an early age, which empowers
the medical community to make well-informed decisions for an individual’s health. The
aim of this investigation was to establish a normative range of data for 18-22 year olds
using IOS/FO and spirometry. Another goal was to examine the effects of gender,
ethnicity, smoking, physical activity, height, weight, and body mass index and percentage
fat on airway and lung function (FEV1).

11

Methods
Participants
Participants in this study were comprised of students between the ages of 18-22
years old from Georgia Southern University’s Healthful Living classes. The participants
were given an incentive (extra credit towards his/her Healthful Living grade). This make
up of participants made for a convenient sampling. Students were in good health with no
significant medical history, especially no cardiopulmonary problems. Each student
included in the study provided informed consent and was able to perform resting
pulmonary function measurements. Those excluded from the study included those who:
had significant cardiopulmonary medical histories, were on prescribed lung medications
at the time of the study, had a history of TB or congenital lung disease or had a
respiratory illness in the last two weeks (sinusitis, pneumonia, upper respiratory infection,
asthma exacerbation, flu, or other cardiopulmonary problems). The study attempted to
include an equal representation of both genders and all ethnicities. Representation of
some groups may be less, due to a smaller percentage of the population density at
Georgia Southern University.
Procedure
The Institutional Review Board (IRB) of Georgia Southern University approved
the study before the collection of data. Subjects signed an informed consent prior to
testing. The informed consent stated the purpose of the study and granted permission to
use information gathered in the study. Data was recorded such that using the prefix GSU
and the last five digits of his/her Eagle ID could not individually identify subjects. The
study was conducted using three parts: participant completion of the self-assessment
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questionnaire, followed by body composition testing, and finally oscillometry and
spirometry testing.
Self-Assessment Questionnaire
Appropriate selected parts of the American Thoracic Society (ATS) questionnaire
(Appendix C) were used to assess respiratory, medical wellness, as well as tobacco usage.
In addition, the Standard Health Activity Questionnaire (Appendix D) was utilized to
assess prior exercise history. The ATS Questionnaire consisted of 52 questions with
multiple parts and the Standard Health Activity Questionnaire consisted of 66 questions
with multiple parts. These questionnaires have been established as valid and reliable
(Larson, Convey, Berry, Wirtz, and Kin, 1993; Wareham, Jakes, Rennie, Mitchell,
Hennings, and Day, 2002). The average time needed to complete the questionnaires did
not exceed 15 minutes.
Body Composition
Weight was measured using a calibrated medical scale. Standing height was
taken, with shoes removed, using a stadiometer. Seated height was also obtained when
the subject was in a seated position with measurements taken using a meter ruler that was
attached to the wall. Next, three-site skinfold measurements were obtained using a
standard protocol (Jackson and Pollack, 1978). The males’ sites were the pectoral,
abdominal and front thigh areas and the females’ sites were the tricep, supra-iliac and
front thigh areas all performed on the right side of the body. Skinfold measurement was
used to estimate percentage of body fat according to the regression equations used by
Jackson and Pollock (1978) and Jackson et al (1980). Standard waist-to-hip
measurements were recorded using a tape measure.
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Oscillometry
Oscillometry was performed using the Jaeger Oscillometer (Jaeger Instruments,
Germany). Oscillometry consists of the subject breathing at rest through a valve. He/she
sat with his/her mouth around the valve, and hands resting on his/her cheeks while
breathing normally through the valve. The subject was allowed approximately 15 to 30
seconds to stabilize his/her breathing pattern on the valve. The technician visually
inspected the presented tidal volume waveforms for stability. Once stability was
established, the testing proceeded. The participant continued resting breathing during
testing for a run of approximately one minute of while oscillatory recordings were
obtained. After each run was completed, the participant performed quiet breathing for 90
seconds before beginning the next test. Once the test was completed, the IOS device
performed a “koherenz” calculation to check for acceptability of the data (American
Thoracic Society, 1995). The ideal value is 1.0 for perfect data. For this project,
acceptable data were values greater than 0.8 at 10 hertz (Hz). Measurements that passed
the quality test were recorded in raw form, and a preliminary analysis was performed.
Three acceptable oscillometry trials, separated by a minute and a half of quiet breathing,
were performed.
Spirometry
Spirograms were performed using a pneumotach (Jaeger Instruments, Germany)
coupled to a personal computer. The first step to spirometry testing was the participant
began breathing at rest through a valve. After the participant stabilized his/her breathing,
he/she inhaled forcefully and exhaled with maximum force for as long as possible, then
returned to a normal, resting breathing state. The participant performed quiet breathing
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for 90 seconds between each run. The participant’s airflow volume loops were visually
inspected for acceptance using established ATS criteria (American Thoracic Society,
1995). An 80% or greater FEV1 is a standard measurement determined by the ATS. If the
results fell outside the acceptance limits, then the test was recorded but was not included
in the analysis. The data collected was used in subsequent analyses evaluating the
consistency of IOS/FO to spirometry.
Data Analysis
The data were analyzed using the Statistical Package for the Social Sciences
(SPSS version 12.0, SPSS, Chicago, IL, USA). Means and standard deviations were
calculated for all variables. Gender differences for age, height, body mass, BMI,
ethnicity and smoking were explored. The relationship of FEV1 with age, body mass,
BMI, and height was examined using Pearson’s correlation coefficient and independent-t
tests were used to assess the relationship between FEV1 and race, gender, physical
activity, and smoking. Regression equations were also computed to examine the
relationship among age, height, weight and gender on resistance (R) and reactance (X).
Significance levels were set at 0.01.
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Results
Descriptive statistics of the study participants are summarized in Table 1. Results
show that women tended to be slightly younger, weighed less and were shorter with
regards to standing height than the men.
Table 1. Anthropometric data of participants
All
Males
Females
participants
(n=49)
(n=93)
(n=142)
Age
(years)

20.08±1.33

20.25±1.37

19.99±1.31

Height
(m)

1.67±.095

1.75±0.75

1.63±0.07

Body
Mass
(kg)

70.57±17.61

81.01±18.95

65.24±14.28

BMI

25.02±5.25

25.92±5.57

24.56±5.05

Results pertaining to race and smoking status by gender are summarized in Table 2.
Fifty-seven percent of the participants were white compared to only 38.7% being black.
The gap between black and white female participants was larger than the gap between
black and white males. Approximately 20% more white females and 15% more white
males participated than his/her black counterpart. Women were heavier smokers than
men. Cigarettes were the most common form of tobacco use, compared to cigars and
pipes.
Table 3 summarizes the relationship between FEV1 and the following factors:
body mass, height, physical activity, age, sex, race, and smoking. Pearson correlation
coefficients were used to establish significance between the variables body mass, height,
and age. A significance was established between FEV1 and the variables standing height
(p=0.000) as well as body mass and FEV1 (p=0.000). The study did not show a
relationship between FEV1 and age, BMI and physical activity. When examining various
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Table 2. Proportion of gender with ethnicity and smoking
status
All
participants
(n=142)

Females
(n=93)

Males
(n=49)

White

57.0%

58.1%

55.1%

Black

38.7%

37.6%

40.8%

Oriental

0.7%

1.1%

4.1%

Other

2.8%

2.2%

0.0%

21.4%

23.0%

18.4%

13.4%

15.0%

10.2%

2.8%

2.2%

4.1%

0.7%

0.0%

2.1%

Cigarettes
have
smoked
currently
smoke
Cigars
Pipes

type of physical activity individually with respect to FEV1, swimming had a significant
relationship to FEV1 (p=0.039). Other physical activities such as cycling, boxing,
running, or weeding had no relationship with FEV1. Independent t-tests were used to
determine whether FEV1 is associated with sex, race, and smoking. Results show that no
significant relationships exist.

Table 3. Factors affecting FEV1
Pearson's correlation
p-values

Independent T-test
p-values

FEV1

FEV1

Age

0.717

Physical
Activity

0.213

Body Mass

0.006*

Race

0.072

BMI

0.176

Sex

0.594

Standing
Height

0.000*

Smoking

0.904

Seated
Height

0.856

* significance at 0.01
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An examination of the spirometry data shows that 37.5% of males and 62.5% of
females had a FEV1 greater than or equal to 80%. In males the low percentage of 37.5%
may not actually reflect males having respiratory problems; it may just reflect the lack of
full effort when trying to complete the spirometry testing. An < 80% FEV1 may be at risk
for Chronic Obstructive Pulmonary Disease (COPD) and confirms the presence of
airflow limitation. Regression equations were generated using the stepwise method for
resistance (R) and reactance (X) at various frequencies or Hz. The predictive equations,
provided in Table 4, were created for females for resistance and reactance at R5hz, 10Hz,
15Hz, and 20Hz and for X5Hz, respectively. Height and weight were the variables
chosen because they have the most important impact on respiratory function. Only for
R5hz were both predictors, weight and height, included in the regression equation. For
males, there were not any significant predictors for either resistance (R) or reactance (X)
frequencies to include in a regression equation (p=0.514) when using the F-test for
regression testing method.

Table 4. Regression equations for females for IOS
parameters
R(5hz) = 1.161-0.531ht+0.001wt
R(10hz) = 0.835-0.308ht
R(15hz) = 0.831-0.312ht
R(20hz) = 0.740-0.260ht
X(5hz) = 0.475+0.209ht
*R=resistance, X=reactance, wt=weight, ht=height

Table 5 shows the range of oscillometry testing frequencies of the participants by gender
at the various testing frequencies of resistance (R) and reactance (X).

18

Table 5. Oscillometry frequency readings
Male

Female

Minimum

Maximum

Mean

Std.
Deviation

0.17
0.17
0.17
0.15
-0.24
-0.16
-0.09
-0.05
-0.01
0.05

0.61
0.52
0.42
0.80
0.00
0.04
0.08
0.14
0.19
0.24

0.3100
0.2723
0.2579
0.2623
-0.1019
-0.0179
0.0192
0.0560
0.0946
0.1490

0.0926
0.078
0.066
0.0997
0.0571
0.0416
0.0398
0.0409
0.0371
0.0370

7.01
0.03

23.74
1.37

12.5928
0.3568

4.32
0.3414

Minimum

Maximum

Mean

Std.
Deviation

R5
R10
R15
R20
X5
X10
X15
X20
X25
X35

0.19
0.18
0.15
-0.06
-0.42
-0.20
-0.13
-0.09
-0.12
-0.19

0.90
0.79
0.70
0.60
0.02
0.04
0.12
0.19
0.25
0.53

0.3968
0.3439
0.3335
0.3266
-0.1359
-0.0276
0.0249
0.0663
0.1076
0.1778

0.1336
0.1125
0.1025
0.1037
0.0651
0.0454
0.0513
0.0579
0.0594
0.0713

Resonant
Frequency
AX

4.49
0.00

29.26
2.73

13.0662
0.5006

4.71
0.4624
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Discussion
The aim of this study was to devise a set of normative ranges using IOS testing
for individuals 18-22 years old. Normative values are important to clinicians to help
assess a patient’s condition and better diagnose problems and symptoms using scientific
numerical results. Even though predictive equations were created for females for various
resistances (R) and reactance (X) frequencies (Table 4), not all frequencies were
accounted for, only the equation for R5hz included both weight and height, and no
predictive equations were created for males. Therefore, complete normative values could
not be established for the group of 18-22 year olds as a whole. Perhaps the small sample
of males contributed to the lack of information gained for their group. The weight
predictor, even though significant as affecting FEV1, was not significant when creating
regression equations, leaving only height as the significant predicator in the regression
equations for females. Furthermore, it is possible that the sample size used for females
may not have been sufficiently large enough to make inferences to the population of
females 18-22 year olds.
The results do not show a significant correlation between FEV1 and smoking or
age. The participants used in this study were 18-22 year olds, therefore, the female’s
lungs have just finished maturing and male’s lungs are still maturing or have just finished
maturing (Gold, Wang, Wypi et al, 1996). This may explain why there was no correlation
between FEV1 and age due to the fact that the participants smoking had not seriously
affected his/her lungs enough to decrease FEV1 in a substantial way. Previous research
suggests that there is a negative relationship between age and smoking frequency: as a
person ages and his/her amount of smoking increases, his/her FEV1 decreases (Pelkonen,
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Notkola, Tukiainen, Tervahauta, Tumilehto, and Nissinen, 2001; Nevill and Holder,
1999; Gold, Wang, Wypij, Speizer, Ware, and Dockery, 1996). The effects of smoking
on the respiratory system are detrimental. Smoking residue affects the physiological and
mechanical structures of the lungs, not allowing them to function properly. This in turn
decreases the FEV1, indicating possible COPD and other fatal diseases. Just a few years of
smoking can decrease a person’s FEV1, and a lifetime of smoking can do irreversible
damage to smoker’s lungs. Intermediate bouts of trying to quit smoking may slow down
the decline of FEV1, the damage to the lungs, and the chances of emphysema, chronic
bronchitis and other conditions influenced by smoking (Pelkonen, Notkola, Tukiainen et
al, 2001; Nevill and Holder, 1999).
Another vital part of conditioning the lungs and respiratory system is physical
activity. Physical activity guidelines set by the American College of Sports
Medicine/Center for Disease Control (ACSM/CDC) state that “adults should accumulate
30 minutes or more of moderate intensive physical activity on most, preferable all days of
the week” to obtain benefits from physical activity (Burke, Carron, and Eys, 2005). For
many individuals this may help to increase or preserve an individual’s respiratory
function. The present study did not show a significant relationship between physical
activity and FEV1 however, there was a trend of increased FEV1 among individuals who
exercised multiple times per week and did various physical activities per week. Physical
activity helps to strengthen the respiratory pump. As age increases, physical activity will
help to preserve respiratory function and improve quality of life.
This study shows that standing height and body mass are significantly correlated
with FEV1. Height and body mass have an effect on the mechanical functioning of the
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lungs (Bottai, Pistelli, Di Pede et al, 2002). Excessive fat that is associated with being
overweight or obese interferes with the mechanical functioning of the lungs, making it
harder for the lungs to work and decreases the amount of air passing through the lungs. A
decrease in body mass will help increase an individual’s capability to breathe and reduce
the amount of work the lungs perform and hence increasing FEV1.
Scientific research and new technology are instrumental in finding ways to
improve quality of life, find cures for diseases, and identify better ways of earlier
detection of medical problems. Using IOS as a means of gathering data from respiratory
patients during resting breathing instead of using spirometry allows for better patient
cooperation, because patients with respiratory difficulties will not have to tax their lungs.
The use of IOS testing also yields reliable data which is comparable to the “gold
standard” testing of spirometry. Although 18-22 year olds are capable of performing
spirometry correctly, using IOS assures that testing each has a probability of testing being
accurately and more easily preformed. ISO/FO testing uses resting breathing, therefore,
it should be able to be properly completed by individuals with previous or current
respiratory illnesses. Not being able to compare collected data to normative values will
delay diagnosis and treatment for 18-22 year olds. Therefore, there is still a need for
further studies and data collection to provide clinicians with this information.
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Appendix A
Limitations, Delimitations, and Assumptions
There are several limitations to this study. There was a lack of randomization in
the sampling procedure. This was a convenient sample by using only subjects who were
in the Georgia Southern Healthful Living Classes. Multiple t-tests were conducted
without adjusting for significance for race. Multiple trained individuals conducted body
compositions. Although there is a ±3% variance for body fat readings, there could be
more of a variance between the results by the different individuals that conducted the
skinfold measurements. Subjects participated during his/her availability; hence, weight
measurements were not taken at the same time of the day for all participants. Therefore,
due diurnal variation, depending on when a person is measured, his/her weight may
fluctuate by a few pounds and bias was not reduced.
One of the delimitations of this study consisted of the age factor, since mostly
younger subjects of the 18-22 age range were included due to the study design of
collecting data from subjects enrolled in the Healthful Living course that is mostly taken
by freshmen and sophomores. Another delimitation of this study was that participants
needed to be in a particular state of health and have no drug restrictions.
Assumptions for this study were that participants did not eat or drink at least three
hours prior to participation, answered the questionnaire fully and honestly, have not been
respiratory compromised in the last two weeks, and gave full maximum effort during
testing.
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Appendix B
Extended Literature Review

The determination of an individual’s lung function is affected by multiple
variables. Different variables affect lung function, some of which cannot be controlled
while others can. Age and height are variables which individuals have no control over.
Aging results in higher rates of decline in pulmonary function (Jakes, Day, Patel et al,
2002; Pelkonen, Notkola, Lakka Tukiainen, Kivinen, and Nissinen, 2003). Aging causes
a possible loss of the lung elastic recoil, which may cause a premature airway closure and
air trapping during forced expiration. Aging is also associated with increased chest wall
compliance, and a decreased strength of respiratory muscles, all of which lead to a
decrease in pulmonary function (Pelkonen, Notkola, Lakka et al, 2003). Variables that
are influenced directly by individual’s lifestyle habits and/or exposure include: history of
cigarette smoking or smoke exposure, one’s level of physical activity, and a person’s
weight (Bottai, Pistelli, Di Pede et al, 2002; Gold, Wang, Wypij et al, 1996; Wise,
Enright, Connett, Anthonisen, Kanner, and Lindgren, 1998). Knowing what variables
influence lung function is crucial for the prevention of the deterioration of one’s lung
function; but another equally crucial aspect is the accurate assessment of lung function.
Proper assessment of lung function is extremely vital for persons with obstruction airway
diseases (asthma, emphysema, chronic bronchitis and COPD) or those who with
restrictive airway disease. The establishment of baseline measurements, diagnosis of
respiratory diseases and different therapeutic strategies are all assessed by the use of
pulmonary function tests (PFT’s) (Vink, Arets, van der Lang and van der Ent, 2003;
McKay, Levin, Lockey, Levin, Lockey, Lemasters, Medvedovic, and Papers, 1999).
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PFT’s provide invaluable information regarding potential change in lung function due to
disease and responses to therapies (McKay, Levin, Lockey et al, 1999). PTF’s provide
information concerning force vital capacity (FVC) and forced expiratory volume (FEV).
The most addictive variable that influences lung function is cigarette smoking or
exposure to cigarette smoke. Smoking is a major source of respiratory illness and
distress. Individuals’ past and current smoking impact lung function in a negative
manner if the individual is susceptible (Nevill and Holder, 1999; Wise, Enright, Connett
et al, 1998; Gold, Wang, Wypij et al, 1996). Shiota et al demonstrated a distinct
difference between smokers and nonsmokers with regard to lung function. Smokers’
lungs seem to be inferior to that of nonsmokers (Nevill and Holder, 1999). People who
have or currently smoke, present with declining lung function and the rates of decline is
accelerated when compared to individuals who have never smoked (Pelkonen, Notkola,
Lakka et al, 2003). Continuing to smoke causes persistently greater decline in lung
function and leads to progressively worsening respiratory problems and diseases. There
was a greater decrease in FEV1, FVC, and FEV/FVC in smoking subjects that is not seen
in nonsmokers (Cheng, Macera, Addy, Sy, Wieland, and Blair, 2003; Shiota, Katoh, Fujii
, Aoki, Matsuka, and Fukuchi, 2005). Compared to age gendered nonsmokers,
adolescents who smoked more than 15 cigarettes per day compared to nonsmokers
exhibited a 4.1% and 3.2% (boys to girls, respectively) reduction of FEF25-75 (Gold,
Wang, Wypij et al, 1996). There was also a decrease in FEF25-75 (3.5% and 3.2% boys to
girls respectively) with each pack of cigarettes smoked per day (Gold, Wang, Wypij et al,
1996). Research has demonstrated that children who smoke have higher rates of asthma
(14% vs. 10%) and wheezing (65% vs. 50%). When looking at FEV1 and FVC, the
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growth rate of adolescents between the ages of 10-18 years old who smoked was 0.76%
slower per year for FVC and for FEV1 the growth rate was 1.09% slower per year than in
adolescents who never smoked (Gold, Wang, Wypij et al, 1996). In adolescent boys and
girls, just small amounts of cigarette smoking caused similar deficits in levels of both
FEV1/FVC and FEF25-75.
The effect of intermitting quitting of smoking has some controversial findings in
different research as to whether or not intermittent quitting is beneficial when it comes to
lung function (Pelkonen, Notkola, Lakka et al, 2003). Pelkonen et al using data from the
Lung Health Study noted those intermittent quitters do benefit. Pelkonen et al results
revealed that people who had quit smoking had a slower decline in FEV0.75 than
continuous smokers. Continuing smokers lost 9.18% predicted FEV1 (p<0.001) and
7.43% predicted FVC (p<0.001) compared with sustained quitters. Other studies
demonstrated that a decline in pulmonary function is faster in those who relapse back to
smoking rather than continuous smokers. Wise et al research concluded that stopping
smoking was shown to slow the decline in lung function.

Nevill et al research yielded

results, where nonsmokers decreased less in FEV1 followed by ex-smokers, and smokers.
Ex-smokers suffered consistent 4-5% reduction in lung function performance in both
FEV1 and FVC for all age groups. Lazarus et al showed that quitting smoking improved
FEV1 in males by 11 ml and in females by 49 ml compared with continued smoking
(Lazarus, Gore, Booth, and Owen, 1998).
Smoking cessation is associated with weight gain (Wise, Enright, Connett et al,
1998). Wise et al conducted a study that examined the effect of cessation of smoking on
body weight. He demonstrated a greater decline in FEV1 in persons who continue to
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smoke than in persons who quit smoking and gained weight. Continuous smokers have a
greater decline in FEV1 than was seen among continuous quitters with the most weight
gain after they quit smoking. The first year of weight gain after smoking cessation has
the largest effect on lung function. The constant fluctuation in body weight can lead to
improvements or decline in lung function. Weight gain has been significantly associated
with falls in both FEV1 and FVC. A 10% increase in weight is associated with 0.83%
predicted fall in FEV1 (p<0.001) and a 1.11% predicted fall in FVC (p<0.001). FEV1
annual declines were greater in those who gained the most weight during follow up
periods. For every kilogram of weight gained per year, FVC declines approximately 16
ml (McKay, Levin, Lockey et al, 1999). There is a linear negative association between
the percentage weight change and the percentage change in FEV1 and is significant in
men and women alike (p<0.001). Individuals who gained weight the fastest
demonstrated the fastest rate of decline in FEV1 (Jakes, Day, Patel et al 2002). Obesity
impairs lung function in several ways by causing alterations in the pressure-volume
characteristics of the thorax, mircoatelectasis from decreased depth of inspiration, and
causes an increased pulmonary blood volume from increased plasma volume (Wise,
Enright, Connett et al, 1998). Even though weight gain negatively effects pulmonary
function, a person would have to gain 60 kilograms to equal the effect that continuous
smoking has on FEV1.
In the first twelve months of smoking cessation 10.2% males and 12.8% females
gained weight of more than 10 kilograms. The mean weight increase was about five
kilograms during the first year in men and women who quit smoking. After five years of
sustained quitting, 33.9% males and 37% females gained more than 10 kilograms,
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compared to the 5.2% males and 1.4% females who continued smoking and gained more
that 10 kilograms (Wise, Enright, Connett et al, 1998). Four and one-tenths percent of
men and 4.7% of women who were sustained quitters gained more than 20 kilograms
compared with 0.2% and 0.4% in continuous smokers. Reduced energy expenditure and
an increase in caloric intake, these are the primary basis for how most weight is gained.
There is a subgroup of people who were not able to get the full health benefits of
smoking cessation due to excessive weight gain after smoking cessation that there is an
effect on lung function. Among the grossly overweight, there seems to be impairment in
ventilatory function. In a study that used men, a negative association with ventilatory
function and body fat in the central or upper body was shown. The intermediate trends
are similar as the body fat proportions increase; there is an association with the decrease
of FVC.
When it pertains to the effect of pulmonary function on the sexes, there seems to
be stark differences between each. During childhood and adolescents there is a natural
rise in lung function, after this period of growth lung function begins to decline (Cheng,
Macera, Addy et al, 2003). Lung development is faster and ends earlier in girls as
compared to boys. Girls reach maximum lung function between 16-18 years old,
whereas, boys’ lung function is still increasing and attains maximum pulmonary function
until the early 20’s (Gold, Wang, Wypij et al, 1996). In conjunction with girls reaching
maximum lung function earlier, adolescent girls are currently smoking at a rate similar to
boys (Gold, Wang, Wypij et al, 1996). In girls at or beyond the growth peak the change
in FVC is 0.85% slower per year, where in boys at the same point (at or beyond growth
peak) the change in FVC is 0.23% slower per year compared to nonsmokers. Similarly,
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the decline in FEV1 is greater for girls 1.12% slower per year, where for boys the decline
is 0.42% slower per year compared to nonsmokers. The ultimate conclusion is that
smoking impacts lung function in girls greater than boys, which may mean greater
deficits in girls (Lazarus et al, 1998).
In adults, longitudinal studies have shown that men have respiratory function
changes that are not seen in women. The reason for this may be that it has been indicated
that women have higher lung efficiency, whereas men have more reserve capacity
(Cheng, Macera, Addy et al, 2003). Women also have initial lower FEV1 and FVC values
than men, but the FEV1/FVC ratio percentage is higher in women than men (Cheng,
Macera, Addy et al, 2003; Mohamed, Maiolo, Iacopino, Pepe, De Daniele, and De
Lorenzno, 2002). Smoking, weight gain and/or body mass index (BMI) effects the lungs
of females differently than males (Cheng, Macera, Addy et al, 2003). Concerning
smoking habits, Wise et al concluded across all smoking categories men showed a
significantly greater loss of FEV1 and FVC than women. Women who smoke seem to
have a higher prevalence of airway hyperresponsiveness than men, and it could possibly
be explained by a lower airway caliber in women.
A risk factor that is seen mostly in women is the association between obesity and
asthma, especially if BMI is greater than or equal to 28, there is an increase in the risk of
acquiring asthma, especially if the patient is obese before and after the asthma onset
(Guerra, Sherrill, Bodadilla, Martinez, and Barbbe, 2002). Women who gained weight
after 18 years old were more likely to acquire asthma than males (Guerra et al, 2002).
Males and females had different effects when it came to BMI. In males, there is a
significant decrease in FEV/FVC and a no significant decrease in FEV/VC. In women
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the opposite happens (Bottai, Pistelli, Di Pede et al, 2002). As men gain body weight
there is a larger reduction in VC. Adult males experience larger losses than females. As
weight increases for men, with each 10% increase in weight men lost 1.14% predicted
FEV1 and 1.08% FVC more than women. In both sexes, skinfold thickness has been
correlated with pulmonary function, showing a decrease in FVC in association to
subcutaneous skinfold thickness. Males have a significantly lower fat mass (FM) and
higher fat free mass (FFM) compared to women. (Mohamed, Maiolo, Iacopino et al,
2002). When it comes to physical activity or lack there of, women but not men had a
significantly negative association between television watching and FEV1 (Jakes, Day,
Patel et al 2002).
Another component that may greatly affect the quality of one’s pulmonary
function is BMI or percentage body fat. BMI is not a measurement of body composition,
however, typically, increases in BMI are related to increases in body weight and
generally body fat. In a study done by Chen et al, it showed how BMI less than 20 in
males and BMI greater than or equal to 28 in females increase prevalence of COPD.
Guerra et al study revealed that patients with asthma and chronic bronchitis had a
significantly higher mean BMI than the control subjects. Even though lung function and
its decline are associated primarily with weight gain, lung function decreases at both
extremes of weight (McKay, Levin, Lockey et al, 1999). The amount, location, and
distribution of body fat can promote and exacerbate many diseases and conditions
including CVD, and glucose tolerance. Fat is metabolically active, therefore, fat deposits
may have a mechanical effect on the ventilatory function (Bottai, Pistelli, Di Pede et al,
2002; Lazarus, Gore, Booth et al;1998, McKay, Levin, Lockey et al, 1999). The
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mechanical effect on the diaphragm may impede expansion of the lungs during
inspiration, which causes a higher impairment on ventilatory function (Bottai, Pistelli, Di
Pede et al, 2002). Ventilatory function requires muscular contraction to overcome air
pressure on the large surface area of the chest wall, therefore, the effect body fat has on
ventilatory function may be limited to obese individuals (Mohamed, Maiolo, Iacopino et
al, 2002). On the other hand, FFM is associated with immune competence, survival and
functional status and has no demonstrated or significant relationship to increase in FVC,
FEV1, and PEF (Lazarus, Gore, and Booth et al, 1998; Mohamed, Maiolo, Iacopino et al,
2002). Women and men store fat differently. Men’s fat is more centrally located,
whereas women’s fat is more peripheral (Bottai, Pistelli, Di Pede et al, 2002). There is a
significant association between the central pattern of fat distribution and the decrease in
ventilatory function in men only when using waist circumference or waist-to-hip ratio
measurement (Bottai, Pistelli, Di Pede et al, 2002; McKay, Levin, Lockey et al, 1999;
Lazarus, Gore, Booth et al, 1998). Lazarus et al showed there is a significant negative
association between percentage body fat and the adjusted FVC. Contradictory to this
study, previous studies have shown weak or no significant association with body mass or
BMI after accounting for age and height. Cheng et al also concluded that BMI is not
associated with respiratory function, but that BMI is associated with lower values of
MTT. The results from Mohamed et al suggest that variables age, height, and weight
components (BF-LBM, BMC) and not weight and FM correlated significantly with FVC,
FEV1 and PEF (P<0.0001) for males and females. Mohamed suggests that even though
the effect of body weight is detectable with lung function, additional variables are needed
to help explain variance. BF-LBM*height and lung function variables had no
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significance in weight or height differences between males and females. There was
significance when examining the direct effect of muscular mass.
Bottai et al have reported a longitudinal decline of FEV1 and FVC with BMI and
body weight gains. BMI’s effects on lung function are higher in males, being
independent of age. As people lose weight, their lung function starts to improve, and as
people gain weight there is a reduction in lung function. Due to the increase in BMI, as
individuals become more obese, there is a higher VC loss and decreases in FVC, and
FEV. Bottai et al suggests that the effect of gaining weight on the decline of pulmonary
function is independent of age, smoking habit, and occupational exposure. By reducing
BMI by one unit improves FEV1, 20 ml in males and 16 ml in females. The reduction of
BMI improved ventilatory function. On the other hand an increase in BMI from 25 to 35
kg/m2 shows a decline of 111 and 141 FVC (males and females respectively). Studies by
Crapo et al, Stalnecker et al, and Coultae et al have researched the effect of gastric and
jejunoileal bypass surgeries on the morbidly obese. These surgeries reported increase in
FVC and FEV of 300 ml and 245 ml respectively after surgery. They reported decrease
in weight by 40 kg, correlated between weight loss and percentage change in FVC, and
declines of FVC, FEV1, with increases in BMI (McKay, Levin, Lockey et al, 1999).
It is reported that 94 million American’s attend college (Burke, Carron and Eys,
2005). As individuals get older their amount of physical activity decreases leading to a
tendency of a sedentary lifestyle becomes greater. For individuals to obtain health
benefits from physical activity the CDC/ACSM Guidelines state that “adults should
accumulate 30 minutes or more of moderate intensity physical activity on most, but
preferable all days of the week” (Burke, Carron, and Eys, 2005). In research done by
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Burke et al, the results indicated that 42.6% of the participants, who were college
students, met CDC/ACSM Guidelines for frequency, intensity and duration. Physical
activity is important for increasing muscular strength, improving cardiovascular
performance, decreasing obesity, counteracting the stiffening tendency in the chest wall
and it promotes longevity (Pelkonen, Notkola, Lakka et al, 2003). Physical activity is a
modifiable risk factor that affects pulmonary function, and by participating in the 30
minutes of recommended physical activity health benefits can be gained. Regular
exercise and good physical fitness produces better pulmonary function (Pelkonen,
Notkola, Lakka et al, 2003). Physical activity may help enhance inspiratory muscle
endurance and may be beneficial to smokers and nonsmokers (Cheng, Macera, Addy et
al, 2003).
With the guidelines set for positive affects on health benefits, there is a mixed
consensus on the effect of physical activity on pulmonary function. Research is split on
the effect of pulmonary function and either its potential to increase or slow the declining
of FEV1 and FVC. Research done by Klijn et al using patients with Cystic Fibrosis
revealed that values after a follow-up visit with aerobic and anaerobic training groups;
physical activity did not change pulmonary function in either group (Klijn, Oudshoorn,
van der Ent, van der Net, Kimpen, 2005). On the hand, physical activity has been shown
to be positively associated with pulmonary function. Pelkonen et al concluded in two
different longitudinal studies that physical activity positively correlated with the level of
FVC in 13-27 year olds, and that there was a slower decline in FEV in those who
participated in physical activity. Jakes et al concluded that there was a significant
positive association between FEV1 and stair climbing, and the amount of vigorous
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recreational activity in men and women. The more stair climbing, the greater decline in
FEVpercentage. Cheng et al research concluded that with the increase of physical
activity levels, there was also an increase in FEV1 and FVC levels, but there was not a
difference in the FEV1/FVC% ratio. This shows that the association between physical
activity and the degree of respiratory obstruction is not supported. Men in the highest
physical activity group, had a much slower adjusted decline of FEV0.75 and in a year the
decline was 9.8 ml per year smaller than individuals in the lowest physical activity group.
People with high-energy expenditures, greater than 2,268 kcal per week, demonstrated a
slower decline in pulmonary function (Pelkonen, Notkola, Lakka et al, 2003). The results
from Jakes et al showed that fitness-inducing aspects of physical activity have an
association with respiratory function. Participants who had a MET score of more than
five had a slower decline in percentage change FEV1. Even with physical activity being a
modifiable risk factor, smoking is the most modifiable risk factor. The effect of physical
activity is not as great as smoking on pulmonary function. The effect of physical activity
on the yearly change in FEV0.75 is smaller than that of smoking (Pelkonen, Notkola,
Tukiainen et al, 2001). However, in individuals who incorporated physical activity into
their lives, they showed a slower decline in FEV0.75 in all smoking categories.
Participating in physical activity in one’s youth is a great way to slow the effects
of age on pulmonary function. Individuals who engage in sports have higher levels of
pulmonary function than sedentary people. A study that examined the pulmonary
function of males and female swimmers concluded that they had larger FEV1 values than
land based athletes or sedentary controls (Cheng, Macera, Addy et al, 2003). Physical
activity may delay the decline in pulmonary function in middle or old age. In previous
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research, it was found that older individuals who are physically active and fit have a
better pulmonary function (Pelkonen, Notkola, Tukiainen et al, 2001). Another study
examined men over a 25 year period, indicates that men in the highest group of physical
activity group lost significantly less FEV0.75 and people who had high levels of physical
activity or changed their lifestyle to include higher levels of physical activity at a younger
age, had a slower decline in FEV0.75 and after 20 years they had higher values of FEV0.75
(Pelkonen, Notkola, Lakka et al, 2003).
Proper assessments, equipment and techniques are required to make an informed
and most importantly an accurate diagnosis for individuals suffering with pulmonary
illness and distress. Lung function consists of measuring lung volume and flows.
Several different techniques are used to assess lung function; body plethysmography,
spirometry and forced oscillometry techniques (FOT). With each technique come its own
advantages and limitations when used in pulmonary assessments. The first pulmonary
test was introduced by Hutchinson in 1846 and was called spirometry (Lazarus, Gore,
Booth et al, 1998; McKay, Levin, Lockey et al, 1999). Hutchinson said about the
spirometer that it is a “precise and easy method of detecting disease” (McKay, Levin,
Lockey et al, 1999). Spirometry is considered the “gold standard” for assessing lung
function and is well documented for assessing, detecting, and measuring lung function
and changes (Kim, Kim, Park et al, 2001; Rigau, Burgos, Hernandez, Roca, Navajas, and
Farre, 2003, Timonen, Randell, Salonen, and Pekkanen, 1997). Spirometry is commonly
used to help assess bronchodilation and measure airway obstruction (Houghton,
Woodcock and Singh, 2004; Kim, Kim, Park et al, 2001; Timonen, Randell, Salonen et
al, 1997). The limitations that are present with spirometric testing is the difficulty found
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in getting full cooperation from patients and completing tests especially in children and
elderly populations (Rigau, Burgos, Hernandez et al, 2003, Timonen, Randell, Salonen et
al, 1997; Houghton, Woodcock, and Singh, 2004; Kim, Kim, Park et al, 2001). For
usable and accurate test results, active cooperation and correct breathing techniques are
needed. Children tend to finish expirations too early (Timonen, Randell, Salonen et al,
1997). Another limitation to using spirometry is that forced maneuvers may affect
bronchomotor tone (Rigau, Burgos, Hernandez et al, 2003; Timonen, Randell, Salonen et
al, 1997). Research conducted by Rigau et al compared FOT and Spirometry, the
standard deviations was larger in the second and third measurements than in the first,
which may suggest that the forced breathing maneuvers may have affected bronchomotor
tone, especially in small airways.
Body plethysmography has been shown to measure physiological changes in
airway resistance effectively. Research by Houghton et al revealed that the use of body
plethysmography an excellent way to measure asthmatics, better than using spirometry or
the impulse oscillometry system (IOS) and was also the most optimum technique for
assessing pharmacological effects on asthma. Limited variability is a limitation created
by using body plethysmography. The more repeated testing done on an individual, the
more of a possibility to reduce variability (Houghton, Woodcock, and Singh, 2004).
Another limitation with using body plethysmography is the high cost for use, making this
technique less utilized by clinicians.
Forced oscillation technique (FOT) was introduced as a technique to correct
limitations seen in the two previous lung function assessing techniques. Nearly a century
later, another method of assessing pulmonary function was invented by DuBois et al
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which was the first oscillatory method for measurement of respiratory system mechanics
and creating a set of pulmonary mechanical parameters (Goldman, Carter, Klein, Fitz,
Carter, and Pachucki, 2002; Kim, Kim, Park et al, 2001). Even though both techniques
(spirometry and FOT) require different types of cooperation from the subject, these two
methods are important assessment tools for clinicians. Impulse oscillometry (IOS) is a
type of FOT (Shiota, Katoh, Fujii et al, 2005). IOS is a way to measure lung function by
only needing passive cooperation from a patient (Marotta, Klinnert, Price et al, 2003;
Kim, Kim, Park et al, 2001; Pasker, Peeters, Genet et al, 1997). IOS works by applying
pulsed pressure flow excitation to the respiratory system and is measured in terms of
resistance and reactance (Marotta, Klinnert, Price et al, 2003; Shiota, Katoh, Fujii et al,
2005). Resistance measures the frictional loss occurring during overflow in the bronchus
(real). Reactance measures the energy stored by more peripheral components of the
respiratory system (imaginary) (Shiota, Katoh, Fujii et al, 2005). The resonant frequency
which is measured in hertz (Hz) is when there is no phase shift between pressure and
flow signal (Hellinckx, Caugerghs, De Boeck, and Demedts, 2001). The advantage of
using IOS over spirometry and body plethysmography is that it can be easily used in
populations such as neonates, young children, and the elderly due to requiring only
passive cooperation (Kim, Kim, Park et al, 2001; Marotta, Klinnert, Price et al, 2003;
Pasker, Peeters, Genet et al, 1997). Tidal breathing is used during IOS, unlike with
spirometry; therefore, there is not any possible effect on the bronchomotor tone
(Timonen, Randell, Salonen et al, 1997).
Data collected from the different types of techniques are compared to spirometry
data. Spirometry data has been shown to be valid, reliable, and reproducible. With
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respect to comparing FOT to spirometry, previous research revealed there is a correlation
between FOT and spirometry (R2=0.83) (Hellinckx, Cauberghs, and De Boeck et al,
2001). FOT was found to be highly reproducible and compatible with FEV1. There was
also a significant association between FOT parameters with FEV1 and MMEF. Another
study examined the repeatability of FOT and compared its values to MEF25 and MMEF,
which is know to be a sensitive indicators of airway obstruction. FOT was found to be
the most sensitive parameter, which appears to be suitable for the detection of short-term
function changes in the respiratory system. Results from Pasker et al revealed that FOT
is as sensitive as spirometry in detecting small across-shift changes in ventilatory
function. Being that IOS is a type of FOT, IOS is also a valid and reliable source of
instrumentation and its data can be compared to FOT data. Previous research with
respect to IOS showed that IOS is as reproducible, valid and reliable as spirometry and
FOT. Research conducted by Shiota et al had a significantly reproducibility (95% CI
within 2 SD). Vink et al concluded that R and X values (resistance and reactance,
respectively) when compared with FEV measurements are significantly correlated. Rvalues correlated better with FEV than X values. R and X values show a significant
change during changes in airflow obstruction, this is a significant correlation with FEV1.
Vink et al along with previous studies showed that lower R frequency (5 Hz) is more
sensitive to detecting small changes in airflow obstruction and lung function than FEV1.
In studies by both Marotta and Vink et al they concluded that IOS was able to detect
significant differences in bronchodilator use in asthmatics at R5 and R10. By using
spirometry there was not any significant differences found. IOS is able to detect
significant differences between asthmatics and healthy subjects. In healthy individuals
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respiratory resistance is relatively constant at different frequencies (Houghton,
Woodcock, and Singh, 2004). In healthy subjects there was a large variability which may
make the use of IOS in healthy subjects a questionable technique for effectiveness
(Houghton, Woodcock, and Singh, 2004).
Research has been reported IOS as being an easy procedure to complete by
individuals of all ages and lung functionality due to passive cooperation that is need to
complete the testing, but there seems to be missing data for individuals between the ages
of 18-22 year old. The considerable amount of research that has been done using
oscillometry has been in the younger population (ages 3-17), younger individuals who are
respiratory compromised, or older adults who are respiratory compromised. There seems
to be a lack of information in the research world that is dedicated or includes the
generation of individuals between the ages of 18-22. Having a set of normative values
for this particular age group will allow clinicians to see if there are trends in lung function
between young adults and adults. It may also give information into how early and rapidly
lung function may begin to decline once lungs are fully matured, and functioning and
how factors such as smoking habits and physical activity contribute to the deterioration of
an individual’s lung function. To date, there are holes in research utilizing oscillometry
when examining person’s cigarette smoking habits and levels of physical activity that
spirometry has conclusive data regarding. By setting normative data researchers may
start taking a more active approach to using oscillometry setting a standard for 18-22 as
much as spirometry is a “gold standard”.
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ID Number

PHYSICAL
ACTIVITY
QUESTIONNAIRE

This questionnaire is designed to find out about
your physical activity in your everyday life.
Please try to answer every question, except when
there is a specific request to skip a section.

Your answers will be treated as
strictly confidential and will be
used only for medical research
Page 1

CAMB/PA/4/1201

Page 2

THE QUESTIONNAIRE IS DIVIDED INTO 3 SECTIONS
• Section A asks about your physical activity patterns in and around the house.
• Section B is about travel to work and your activity at work.
It may be skipped by people who have not worked at any stage during
the last 12 months.
• Section C asks about recreations that you may have engaged in during the
last 12 months.

What is your date of birth?

day

What is today’s date?

day

Your sex (Please tick (✓) appropriate box)?

Section A

/
/

month

month

Male

/
/

year

year

Female

HOME ACTIVITIES

GETTING UP AND GOING TO BED
Please put a time in each box
Average over the past year
At what time do you
normally get up?

At what time do you
normally go to bed?

On a weekday
On a weekend day

GETTING ABOUT — Apart from going to work
Which form of transport do you use most often apart from your journey to and from work?
Please tick (✓) one box ONLY per line
Distance
of journeys

Car

Usual mode of transport
Walk
Public transport

less than one mile
1–5 mile(s)
More than 5 miles
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Cycle

TV OR VIDEO VIEWING
Please put a tick (✓) on every line
Av e r a g e o v e r t h e l a s t 1 2 m o n t h s
Hours of TV or Video
watched per day

None

less than
1 hour
a day

1 to 2
hours
a day

2 to 3
hours
a day

3 to 4
hours
a day

More than
4 hours
a day

On a weekday before 6 pm
On a weekday after 6 pm
On a weekend day before 6 pm
On a weekend day after 6 pm
STAIR CLIMBING AT HOME
Please put a tick (✓) on every line
Aver age over t he l ast 12 months

Number of times you climbed up a
flight of stairs (approx 10 steps)
each day at home

None 1 to 5
times
a day

6 to 10
times
a day

11 to 15 16 to 20
times
times
a day
a day

More than
20 times
a day

On a weekday
On a weekend day
ACTIVITIES IN AND AROUND THE HOME
Please put a tick (✓) on every line
Average over the last 12 months
Approximate
number of hours
each week

None

Less
than 1
hour a
week

1 to 3
hours
a week

Preparing food, cooking
and washing up
Shopping for food
and groceries
Shopping and browsing in
shops for other items
(e.g. clothes,toys)
Cleaning the house
Doing the laundry
and ironing
Caring for pre-school
children or babies at home
(not as paid employment)
Caring for handicapped, elderly
or disabled people at home
(not as paid employment)
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3 to 6
hours
a week

6 to 10 10 to 15
hours
hours
a week a week

More than
15 hours
a week

Section B

A C T I V I T Y AT W O R K

Please answer this section only if you have been in paid employment at any time during the last
12 months or you have done regular, organised voluntary work.
If not please go to page 9
TYPES OF WORK DURING THE LAST TWELVE MONTHS

•

We would like to know what full or part-time jobs you have done in the last 12 months.

•

You may have held a single job or have held two jobs at once.

•

If you have changed jobs with the same employer, you should enter it as
a change of job only if it entailed a substantial change in physical effort.

EXAMPLE
Someone who worked full-time for 6 months, then retired, rested for 3 months and then started
a voluntary job for 6 hours a week, would complete the questions as follows.

Name of occupation

A
X
E

How many hours per week
did you usually work?

For how many months in the last
12 months did you do this work?

E
L
P
M
Job 1

Job 2

nurse

shop work

38

6

6

3

ACTIVITY LEVELS AT YOUR WORK
Now we would like you to take the total number of hours you worked per week in each job and
divide them up according to your activity level.
Please complete EACH line
Job 1
No

Job 2

Yes

Hours per week

No Yes

✓

6

✓

Hours per week

Sitting — light work
e.g. desk work, or driving a car or truck

Sitting — moderate work
e.g. working heavy levers or riding
a mower or forklift truck

A
X
E

Standing — light work

e.g. lab technician work or working
at a shop counter

E
L
MP
✓

✓

30

✓

2

✓

2

✓

4

Standing — light/moderate work
e.g. light welding or stocking shelves

✓

The number of hours in each activity should add up to the number of hours that you worked in
each job e.g. 6+30+2=38 (nurse)
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What jobs have you held in the last 12 months, and how many months in the year did
you do them?
Please complete EACH line
Job 1

Job 2

Name of occupation
How many hours per week
did you usually work?
For how many months in the last
12 months did you do this work?

ACTIVITY LEVELS AT YOUR WORK
Now we would like you to take the total number of hours you worked per week in each job and
divide them up according to your activity level.
Please complete EACH line
Job 1
No

Yes

Sitting — light work
e.g. desk work, or driving a car or truck

Sitting — moderate work
e.g. working heavy levers or riding
a mower or forklift truck

Standing — light work
e.g. lab technician work or working
at a shop counter

Standing — light/moderate work
e.g. light welding or stocking shelves

Standing — moderate work
e.g. fast rate assembly line work or
lifting up to 50 lbs every 5 minutes
for a few seconds at a time

Standing — moderate/heavy work
e.g. masonry/painting or lifting more
than 50 lbs every 5 minutes for a few
seconds at a time

Walking at work — carrying
nothing heavier than a briefcase
e.g. moving about a shop

Walking — carrying something
heavy
Moving, pushing heavy objects
objects weighing over 75lbs
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Hours per week

Job 2
No Yes

Hours per week

STAIR OR STEP CLIMBING AT WORK
Please put a tick (✓) on EACH line where appropriate
Number of times you climbed up
a flight of stairs (10 steps) at work

AVERAGE OVER THE LAST 12 MON TH S
None

1 to 5
times
a day

6 to 10
times
a day

11 to 15
times
a day

16 to 20
times
a day

More than
20 times
a day

Job 1
Job 2

Please put a tick (✓) on EACH line where appropriate
Number of times you climbed up
a ladder at work

AVERAGE OVER THE LAST 12 MON TH S
None

1 to 5
times
a day

6 to 10
times
a day

11 to 15
times
a day

16 to 20
times
a day

More than
20 times
a day

kneel for more than one hour in total?

No

Yes

Don’t know

squat for more than one hour in total?

No

Yes

Don’t know

get up from kneeling or squatting more than 30 times?

No

Yes

Don’t know

kneel for more than one hour in total?

No

Yes

Don’t know

squat for more than one hour in total?

No

Yes

Don’t know

get up from kneeling or squatting more than 30 times?

No

Yes

Don’t know

Job 1
Job 2

KNEELING AND SQUATTING AT WORK IN JOB 1
In an average working day in Job 1 did you

KNEELING AND SQUATTING AT WORK IN JOB 2
In an average working day in Job 2 did you
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TRAVEL TO AND FROM WORK

JOB 1
Please complete EVERY line
Roughly how many miles was it from home to Job 1?
How many times a week did you travel from home to Job 1?
Please tick (✓) one box ONLY per line
How did you normally travel to Job 1?

Always

Usually

Occasionally

Never or rarely

Occasionally

Never or rarely

By car
By works or public transport
By bicycle
Walking

JOB 2 (if appropriate)
Please complete EVERY line
Roughly how many miles was it from home to Job 2?
How many times a week did you travel from home to Job 2?
Please tick (✓) one box ONLY per line
How did you normally travel to Job 2?

Always

By car
By works or public transport
By bicycle
Walking
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Usually

R E C R E AT I O N

Section C

The following questions ask about how you spent your leisure time.
Please indicate how often you did each activity on average over the last 12 months.
For activities that are seasonal, e.g. cricket or mowing the lawn, please put the average frequency
during the season when you did the activity.
Please indicate the average length of time that you spent doing the activity on each occasion.
EXAMPLE
If you had mowed the lawn every fortnight in the grass cutting season and took 1 hour and 10
minutes on each occasion.
If you went walking for pleasure for 40 minutes once a week.
You would complete the table below as follows:

Please give an answer for the AVERAGE TIME you spent on each activity and the NUMBER
OF TIMES you did that activity in the past year.

Number of times you did the
activity in the last 12 months

E
L
P
M
A

None

EX

Mowing the lawn

Average
time per
episode

Less
Once 2 to 3 Once
than
a
times
a
once a month
a
week
month
month

2 to 3
times
a
week

4 to 5 Every
times
day
a
week

✓

1

✓

Walking for pleasure

Now please complete the table on pages 10 and 11
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Hours Mins

10
40

Please give an answer for the NUMBER OF TIMES you did the following activities in the
last 12 months and the AVERAGE TIME you spent on each activity.
Please complete EACH line
Number of times you did the
activity in the last 12 months
None

Less
Once 2 to 3 Once
than
a
times
a
once a month
a
week
month
month

2 to 3
times
a
week

4 to 5 6 times
times a week
a
or
week more

Average
time per
episode
Hours Mins

Swimming —
competitive
Swimming —
leisurely
Backpacking or
mountain climbing
Walking for pleasure
— you should not include
walking as a means of
transportation as this was
included in Sections A & B

Racing or rough
terrain cycling
Cycling for pleasure
— you should not include
cycling as a means of
transportation

Mowing the lawn
— during the grass cutting
season

Watering the lawn or
garden in the summer
Digging, shovelling or
chopping wood
Weeding or pruning
DIY e.g. carpentry, home
or car maintenance

High impact aerobics
or step aerobics
Other types of aerobics
Exercises with weights
Conditioning exercises
e.g. using an exercise bike
or rowing machine

Please continue on the next page
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Please complete EACH line
Number of times you did the
activity in the last 12 months
None

Less
Once 2 to 3 Once
than
a
times
a
once a month
a
week
month
month

2 to 3
times
a
week

4 to 5 6 times
times a week
a
or
week more

Floor exercises
e.g. stretching, bending,
keep fit or yoga

Dancing
e.g. ballroom or disco

Competitive running
Jogging
Bowling
— indoor, lawn or 10 pin

Tennis or badminton
Squash
Table tennis
Golf
Football, rugby or
hockey (during the season)
Cricket (during the season)
Rowing
Netball, volleyball or
basketball
Fishing
Horse-riding
Snooker, billiards or darts
Musical instrument
playing or singing
Ice-skating
Sailing, wind-surfing
or boating
Martial arts, boxing or
wrestling

You have finished the questionnaire — Thank you
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Average
time per
episode
Hours Mins
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